Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update
Ultragenyx (NASDAQ: RARE) will host a conference call on Tuesday, May 5, 2026 at 5:00 p.m. ET to discuss first quarter 2026 financial results and provide a corporate update.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ultragenyx (NASDAQ: RARE) will host a conference call on Tuesday, May 5, 2026 at 5:00 p.m. ET to discuss first quarter 2026 financial results and provide a corporate update. The live webcast and a replay (available for three months) will be on the company's investor website.
Details
News Market Reaction – RARE
On Apr 29, the day this news came out, RARE closed 1.43% below the previous close.
Data tracked by StockTitan Argus for the Apr 29 session.
Key Figures
- Conference call time
- 5:00 p.m. ET
- First quarter 2026 financial results and corporate update
- Call date
- Tuesday, May 5, 2026
- Scheduled earnings and corporate update conference call
- Quarter end date
- March 31, 2026
- Period to be discussed on the earnings call
- Replay availability
- Three months
- Duration the webcast replay will remain accessible
Previous Conferences,earnings Reports
-
Scheduled Q4 and full-year 2025 earnings and corporate update call.
-
Announced Q3 2025 results and corporate update conference call.
-
Scheduled Q2 2025 earnings and corporate update webcast.
-
Set date for Q1 2025 financial results and corporate update call.
-
Announced Q4 and full-year 2024 earnings and corporate update call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NOVATO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Tuesday, May 5, 2026, to discuss its financial results and corporate update for the quarter ending March 31, 2026.
The live and replayed webcast of the call will be available through the company’s website at https://ir.ultragenyx.com/events-presentations. The replay of the call will be available for three months.
About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.
Contact Ultragenyx
Investors
Joshua Higa
ir@ultragenyx.com
Media
Jess Rowlands
media@ultragenyx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.